Home / Blog / Why Location Matters – Medtech

Why Location Matters

For organisations developing medical technologies, diagnostics, digital health solutions, and next-generation medical devices, location is far more than a practical consideration. It can directly influence the speed of innovation, access to expertise, and the ability to bring new solutions to patients and healthcare providers.

In medtech, innovation rarely happens within the walls of a single organisation. Successful breakthroughs emerge from close collaboration between engineers, clinicians, researchers, entrepreneurs, and industry partners. Being part of an established innovation ecosystem creates opportunities to accelerate development, validate technologies, and navigate increasingly complex regulatory and healthcare landscapes.

At Kadans Science Partner, we see how strong sciences clusters enable medtech organisations to build valuable partnerships, access critical resources, and shorten the journey from concept to market.

The most successful science clusters are shaped by a combination of talent, capital, knowledge, and specialised assets. Together, these factors create an environment where medtech companies can develop, test, and scale their innovations more effectively.

Below, we explore the four key reasons why location should be a strategic consideration for medtech organisations.

1. Talent: The teams that drive innovation

Medtech innovation depends on a unique blend of expertise. Successful organisations often require professionals with expertise in engineering, data science, clinical practice, regulatory affairs, quality management, and commercialisation.

As demand for these skills continues to grow, organisations are increasingly drawn to regions with established talent pipelines. For medtech companies, access to highly specialised professionals can be a deciding factor when selecting a location.

Leading science clusters are typically anchored by universities, university medical centres, or other research institutions. Proximity to these organisations provides access to graduates, PhD’s, clinicians, researchers, and experienced industry professionals, while also creating opportunities for internships, collaborative projects, and talent development programmes.

These clusters also attract individuals who want to work at the forefront of healthcare innovation. As expertise becomes concentrated within a region, that concentration generates a powerful network effect, strengthening the ecosystem and increasing its attractiveness to both organisations and talent alike.

2. Capital: Fuelling development and commercialisation

Bringing a medical technology to market requires substantial investment, often across multiple stages of development. From prototyping and clinical validation to regulatory approval and market entry, medtech companies frequently face long timelines and significant capital requirements.

Establishing a presence within a mature innovation ecosystem can increase access to investors who understand the realities of the sector. Alongside public funding programmes, successful clusters often bring together venture capital firms, corporate investors, healthcare innovation funds, and strategic industry partners with experience in scaling medical technologies.

In these environments, introductions and opportunities often emerge through everyday interactions and industry events organised on location. Relationships that begin informally can evolve into strategic partnerships or investment opportunities.

By locating within a cluster where healthcare and technology investment is already active, organisations can increase their visibility among stakeholders who recognise both the challenges and the long-term value of medtech innovation.

3. Knowledge: Turning expertise into progress

Knowledge exchange is one of the defining characteristics of successful science clusters. Close proximity to academic institutions, research centres, and hospitals creates an environment where ideas, expertise, and practical experience can be shared freely.

For medtech developers, collaboration with clinicians is particularly valuable. Early access to healthcare professionals helps organisations better understand clinical needs, validate concepts, and refine technology based on real-world feedback. This can improve development outcomes and support a smoother path towards adoption within healthcare systems.

In a sector where innovation increasingly sits at the intersection of healthcare, engineering, data, and digital technologies, access to diverse expertise can be a significant competitive advantage.

4. Specialised assets: Infrastructure that enables innovation

Developing and validating medical technologies requires facilities that go well beyond conventional office or laboratory space.

Depending on the technology, organisations may require cleanrooms, testing environments, high-quality laboratories, advanced imaging facilities, and so on.

Building this infrastructure independently can be costly and time-consuming. By locating within a science cluster, medtech organisations can often benefit from access to shared facilities, specialised equipment, and technical resources that support development.

At the same time, organisations need dedicated environments tailored to their own operational requirements. Purpose-built research spaces help ensure efficient workflows, support compliance processes, and create the conditions necessary for growth.

Kadans Science Partner develops and operates these specialised assets, supporting organisations long after they move in. With over 20 years of experience, Kadans’ in-house team is well-equipped to develop the environment an organisation requires. Unlike traditional landlords that deliver empty spaces, Kadans provides spaces that are primed to fit each organisation’s specific research needs, providing a seamless transition from lease signing to the commencement of operations.

Every science cluster offers its own unique strengths, shaping the opportunities available to organisations within it. Across the 20 life sciences clusters in our European network, we see how each ecosystem contributes distinct expertise and collaboration potential. Together, they form a connected environment where progress can happen even faster.

The right science cluster can provide access to the talent, capital, knowledge, and infrastructure that support long-term success.

Don’t just seek a place to work, find a place where your organisation can truly grow. Because when it comes to healthcare innovation, where you innovate can be just as important as what you innovate.